Check out all of the coverage of this year’s World Transplant Congress by eAJKD’s Dr. Vinay Nair on Twitter (@eAJKD) and below: Detection of C3d binding donor specific [...]

Dr. Kent from Mt. Sinai, NY, presented interesting data about outcomes of kidney sharing in the NY organ donor network.  Patients listed for kidney transplantation in NY [...]

2. C1 inhibitor (C1INH) If you remember your allergy immunology rotation you may remember that this drug is approved for hereditary angioedema. It works proximally in the [...]

Anyone who takes care of kidney transplant patients knows how frustrating it is dealing with HLA antibodies. This includes pre-transplant HLA antibodies, which can make it [...]

Membranous nephropathy (MN) is a relatively common glomerular disease. Recent advances point to PLA2 antibodies playing a role in its pathophysiology. There were a few [...]

2. Soluble CASK – a new factor implicated in recurrent FSGS The last post left us back to square one in finding the elusive circulating factor responsible for recurrent [...]

Recurrent GN after transplant can be difficult to deal with. I mean if someone is already going to be on a CNI, mycophenolate mofetil, and prednisone what more can you do? [...]

Kidney paired donation or kidney “swaps” not only receive a lot of media, but are quickly becoming the “treatment” of choice for incompatible donor [...]

In the last plenary session of the day, Dr. Madhav Menon from Mt. Sinai, NY, presented an interesting study that really exemplifies translational research. The story of the [...]

In kidney transplantation one of the largest challenges is in understanding antibody-mediated injury. During the first plenary session at the World Transplant Congress, Dr. [...]